{"alopecia": 2.5, "death": 7.49, "disease progression": 2.95, "dysphagia": 5.43, "general physical health deterioration": 2.71, "hospitalisation": 4.24, "hyperpyrexia": 10.24, "maligt melanoma": 32.53, "maligt neoplasm progression": 10.98, "metastases to central nervous system": 36.74, "metastatic maligt melanoma": 181.24, "palmoplantar keratoderma": 546.38, "product use in unapproved indication": 2.8, "pyrexia": 2.81, "skin papilloma": 66.1, "uveitis": 33.57}